DUKX yields 2.41% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 8
Combined, DUKX + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DUKX + JNJ for your $10,000?
DUKX invests in unaffiliated global ex-US equity ETFs using a proprietary trend-following strategy. The underlying ETFs, either passively managed or actively managed, may invest in developed market ex-US and emerging market equities of any market cap. The fund expects to allocate nearly all its assets to these ETFs. In selecting investments, the adviser determines buy and sell signals by calculating the upper and lower bands of the short-term exponential moving averages. A buy signal is initiated when a potential uptrend in a candidate ETF is detected. To limit drawdowns of the overall fund, an ETF is sold when a sell signal is identified. Upon selling a position, the fund may reinvest in another ETF or temporarily hold cash equivalents, including US T-bills, money market funds, and investment-grade short-term bond ETFs. The fund is not limited by any constraints on the number or type of underlying ETFs. The adviser periodically reviews and adjusts the allocation of the fund.
Full DUKX Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.